Related Experiment Video
Updated: Aug 8, 2026
06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
The comparative pathology of Clostridium difficile-associated disease
1The University of Arizona, Department of Veterinary Sciences and Microbiology, Building #90, Room 212, 1117 East Lowell St., Tucson, AZ 85721, USA.
Veterinary Pathology
|May 5, 2006
Summary
Clostridium difficile causes disease in many mammals, with severity varying by host species and age. Its toxins A and B disrupt cellular function, leading to illness, but factors influencing susceptibility require further study.
Area of Science:
- Veterinary Medicine
- Microbiology
- Pathogen Research
Background:
- Clostridium difficile is a significant pathogen across diverse mammalian species.
- Disease incidence and lesion presentation in Clostridium difficile infections (CDI) vary considerably based on host factors.
- Susceptibility differences among species and age groups are not fully understood.
Purpose of the Study:
- To review the variable impact of Clostridium difficile across mammalian hosts.
- To discuss the known and proposed mechanisms of Clostridium difficile virulence.
- To highlight gaps in understanding host-specific disease susceptibility.
Main Methods:
- Literature review of Clostridium difficile-associated disease in mammals.
- Analysis of factors influencing disease incidence and severity.
- Summary of known C. difficile virulence factors and their mechanisms.
Main Results:
- Clostridium difficile affects numerous mammals, with Syrian hamsters, horses, and pigs commonly diagnosed.
- Toxin A (TcdA) and Toxin B (TcdB) are key virulence factors, disrupting the actin cytoskeleton via Rho-subtype signaling.
- Variable host susceptibility may relate to colonization rates and toxin-receptor interactions.
Conclusions:
- Clostridium difficile pathogenesis involves complex host-pathogen interactions.
- Further research is needed to elucidate receptor-mediated toxin activity and species-specific susceptibility.
- Understanding these factors is crucial for managing Clostridium difficile-associated disease in veterinary medicine.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...